197 related articles for article (PubMed ID: 9573030)
1. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
[TBL] [Abstract][Full Text] [Related]
2. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
[TBL] [Abstract][Full Text] [Related]
3. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
[TBL] [Abstract][Full Text] [Related]
4. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
5. T-cell prolymphocytic leukemia with der(11)t(1;11)(q21;q23) and ATM deficiency.
Yamaguchi M; Yamamoto K; Miki T; Mizutani S; Miura O
Cancer Genet Cytogenet; 2003 Oct; 146(1):22-6. PubMed ID: 14499692
[TBL] [Abstract][Full Text] [Related]
6. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
[TBL] [Abstract][Full Text] [Related]
7. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
8. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
9. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
[TBL] [Abstract][Full Text] [Related]
10. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
11. ATM is usually rearranged in T-cell prolymphocytic leukaemia.
Yuille MA; Coignet LJ; Abraham SM; Yaqub F; Luo L; Matutes E; Brito-Babapulle V; Vorechovský I; Dyer MJ; Catovsky D
Oncogene; 1998 Feb; 16(6):789-96. PubMed ID: 9488043
[TBL] [Abstract][Full Text] [Related]
12. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia.
Takeuchi S; Koike M; Park S; Seriu T; Bartram CR; Taub HE; Williamson IK; Grewal J; Taguchi H; Koeffler HP
Br J Haematol; 1998 Nov; 103(2):536-8. PubMed ID: 9827931
[TBL] [Abstract][Full Text] [Related]
13. No germline ATM mutation in a series of 16T-cell prolymphocytic leukemias.
Stoppa-Lyonnet D; Laugé A; Sigaux F; Stern MH
Blood; 2000 Jul; 96(1):374-6. PubMed ID: 10939806
[No Abstract] [Full Text] [Related]
14. ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
[TBL] [Abstract][Full Text] [Related]
15. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ATM gene mutations in 66 ataxia telangiectasia families.
Sandoval N; Platzer M; Rosenthal A; Dörk T; Bendix R; Skawran B; Stuhrmann M; Wegner RD; Sperling K; Banin S; Shiloh Y; Baumer A; Bernthaler U; Sennefelder H; Brohm M; Weber BH; Schindler D
Hum Mol Genet; 1999 Jan; 8(1):69-79. PubMed ID: 9887333
[TBL] [Abstract][Full Text] [Related]
19. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
Camacho E; Hernández L; Hernández S; Tort F; Bellosillo B; Beà S; Bosch F; Montserrat E; Cardesa A; Fernández PL; Campo E
Blood; 2002 Jan; 99(1):238-44. PubMed ID: 11756177
[TBL] [Abstract][Full Text] [Related]
20. ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Haidar MA; Kantarjian H; Manshouri T; Chang CY; O'Brien S; Freireich E; Keating M; Albitar M
Cancer; 2000 Mar; 88(5):1057-62. PubMed ID: 10699895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
